China National Accord Medicines Corp Ltd (000028) - Net Assets

Latest as of September 2025: CN¥21.55 Billion CNY ≈ $3.15 Billion USD

Based on the latest financial reports, China National Accord Medicines Corp Ltd (000028) has net assets worth CN¥21.55 Billion CNY (≈ $3.15 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥50.56 Billion ≈ $7.40 Billion USD) and total liabilities (CN¥29.01 Billion ≈ $4.24 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 000028 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥21.55 Billion
% of Total Assets 42.63%
Annual Growth Rate 18.3%
5-Year Change 22.9%
10-Year Change 272.86%
Growth Volatility 39.21

China National Accord Medicines Corp Ltd - Net Assets Trend (1992–2024)

This chart illustrates how China National Accord Medicines Corp Ltd's net assets have evolved over time, based on quarterly financial data. Also explore China National Accord Medicines Corp Ltd balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for China National Accord Medicines Corp Ltd (1992–2024)

The table below shows the annual net assets of China National Accord Medicines Corp Ltd from 1992 to 2024. For live valuation and market cap data, see how much is China National Accord Medicines Corp Ltd worth.

Year Net Assets Change
2024-12-31 CN¥20.76 Billion
≈ $3.04 Billion		 -1.06%
2023-12-31 CN¥20.98 Billion
≈ $3.07 Billion		 +7.88%
2022-12-31 CN¥19.44 Billion
≈ $2.85 Billion		 +7.89%
2021-12-31 CN¥18.02 Billion
≈ $2.64 Billion		 +6.71%
2020-12-31 CN¥16.89 Billion
≈ $2.47 Billion		 +9.95%
2019-12-31 CN¥15.36 Billion
≈ $2.25 Billion		 +10.46%
2018-12-31 CN¥13.91 Billion
≈ $2.03 Billion		 +40.07%
2017-12-31 CN¥9.93 Billion
≈ $1.45 Billion		 +11.37%
2016-12-31 CN¥8.91 Billion
≈ $1.30 Billion		 +60.14%
2015-12-31 CN¥5.57 Billion
≈ $814.55 Million		 +14.74%
2014-12-31 CN¥4.85 Billion
≈ $709.89 Million		 +109.41%
2013-12-31 CN¥2.32 Billion
≈ $339.00 Million		 +25.97%
2012-12-31 CN¥1.84 Billion
≈ $269.11 Million		 +28.89%
2011-12-31 CN¥1.43 Billion
≈ $208.79 Million		 +26.10%
2010-12-31 CN¥1.13 Billion
≈ $165.57 Million		 +28.85%
2009-12-31 CN¥878.13 Million
≈ $128.50 Million		 +35.23%
2008-12-31 CN¥649.37 Million
≈ $95.02 Million		 +25.46%
2007-12-31 CN¥517.58 Million
≈ $75.74 Million		 +9.45%
2006-12-31 CN¥472.90 Million
≈ $69.20 Million		 +20.11%
2005-12-31 CN¥393.72 Million
≈ $57.61 Million		 +9.92%
2004-12-31 CN¥358.20 Million
≈ $52.42 Million		 +4.47%
2003-12-31 CN¥342.86 Million
≈ $50.17 Million		 +2.44%
2002-12-31 CN¥334.70 Million
≈ $48.98 Million		 -8.16%
2001-12-31 CN¥364.45 Million
≈ $53.33 Million		 -10.02%
2000-12-31 CN¥405.06 Million
≈ $59.27 Million		 -10.43%
1999-12-31 CN¥452.23 Million
≈ $66.18 Million		 +0.89%
1998-12-31 CN¥448.25 Million
≈ $65.59 Million		 +36.59%
1997-12-31 CN¥328.17 Million
≈ $48.02 Million		 -8.11%
1996-12-31 CN¥357.13 Million
≈ $52.26 Million		 +8.33%
1995-12-31 CN¥329.65 Million
≈ $48.24 Million		 +2.09%
1994-12-31 CN¥322.91 Million
≈ $47.25 Million		 +12.44%
1993-12-31 CN¥287.19 Million
≈ $42.02 Million		 +199.84%
1992-12-31 CN¥95.78 Million
≈ $14.02 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to China National Accord Medicines Corp Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1257749808094.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥12.58 Billion 71.17%
Common Stock CN¥556.57 Million 3.15%
Other Comprehensive Income CN¥2.55 Billion 14.42%
Other Components CN¥1.99 Billion 11.26%
Total Equity CN¥17.67 Billion 100.00%

China National Accord Medicines Corp Ltd Competitors by Market Cap

The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their market capitalization.

Company Market Cap
IMAX Corporation
F:IMA
 $1.74 Billion
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
 $1.74 Billion
360 Finance Inc
NASDAQ:QFIN
 $1.74 Billion
Adecoagro S.A
F:ACD
 $1.74 Billion
Vishay Intertechnology Inc
NYSE:VSH
 $1.74 Billion
PSK Inc
KQ:319660
 $1.74 Billion
Gas Malaysia Bhd
KLSE:5209
 $1.74 Billion
Gujarat State Petronet Limited
NSE:GSPL
 $1.74 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in China National Accord Medicines Corp Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 17,414,808,729 to 17,669,528,000, a change of 254,719,271 (1.5%).
  • Net income of 642,493,457 contributed positively to equity growth.
  • Dividend payments of 603,765,665 reduced retained earnings.
  • Other comprehensive income increased equity by 2,539,808,798.
  • Other factors decreased equity by 2,323,817,319.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥642.49 Million +3.64%
Dividends Paid CN¥603.77 Million -3.42%
Other Comprehensive Income CN¥2.54 Billion +14.37%
Other Changes CN¥-2.32 Billion -13.15%
Total Change CN¥- 1.46%

Book Value vs Market Value Analysis

This analysis compares China National Accord Medicines Corp Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.78x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 73.74x to 0.78x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1992-12-31 CN¥0.33 CN¥24.54 x
1993-12-31 CN¥1.00 CN¥24.54 x
1994-12-31 CN¥1.12 CN¥24.54 x
1995-12-31 CN¥1.14 CN¥24.54 x
1996-12-31 CN¥1.24 CN¥24.54 x
1997-12-31 CN¥1.13 CN¥24.54 x
1998-12-31 CN¥1.18 CN¥24.54 x
1999-12-31 CN¥1.19 CN¥24.54 x
2000-12-31 CN¥1.12 CN¥24.54 x
2001-12-31 CN¥1.23 CN¥24.54 x
2002-12-31 CN¥1.16 CN¥24.54 x
2003-12-31 CN¥1.19 CN¥24.54 x
2004-12-31 CN¥1.24 CN¥24.54 x
2005-12-31 CN¥1.37 CN¥24.54 x
2006-12-31 CN¥1.19 CN¥24.54 x
2007-12-31 CN¥1.29 CN¥24.54 x
2008-12-31 CN¥1.66 CN¥24.54 x
2009-12-31 CN¥2.20 CN¥24.54 x
2010-12-31 CN¥2.82 CN¥24.54 x
2011-12-31 CN¥3.61 CN¥24.54 x
2012-12-31 CN¥4.74 CN¥24.54 x
2013-12-31 CN¥6.00 CN¥24.54 x
2014-12-31 CN¥10.67 CN¥24.54 x
2015-12-31 CN¥9.90 CN¥24.54 x
2016-12-31 CN¥15.34 CN¥24.54 x
2017-12-31 CN¥16.88 CN¥24.54 x
2018-12-31 CN¥20.89 CN¥24.54 x
2019-12-31 CN¥23.01 CN¥24.54 x
2020-12-31 CN¥25.06 CN¥24.54 x
2021-12-31 CN¥26.82 CN¥24.54 x
2022-12-31 CN¥28.97 CN¥24.54 x
2023-12-31 CN¥31.29 CN¥24.54 x
2024-12-31 CN¥31.63 CN¥24.54 x

Capital Efficiency Dashboard

This dashboard shows how efficiently China National Accord Medicines Corp Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 3.64%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.86%
  • • Asset Turnover: 1.56x
  • • Equity Multiplier: 2.69x
  • Recent ROE (3.64%) is below the historical average (11.91%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1992 21.59% 24.47% 0.45x 1.97x CN¥11.11 Million
1993 11.37% 27.34% 0.31x 1.34x CN¥3.94 Million
1994 11.16% 27.95% 0.34x 1.18x CN¥3.73 Million
1995 7.10% 14.47% 0.42x 1.16x CN¥-9.53 Million
1996 11.37% 26.73% 0.34x 1.25x CN¥4.88 Million
1997 -8.64% -33.33% 0.17x 1.52x CN¥-60.86 Million
1998 1.60% 6.17% 0.16x 1.65x CN¥-28.61 Million
1999 6.02% 22.83% 0.17x 1.58x CN¥-13.58 Million
2000 -2.41% -7.22% 0.22x 1.52x CN¥-40.09 Million
2001 5.96% 1.26% 1.49x 3.16x CN¥-14.30 Million
2002 1.48% 0.26% 1.78x 3.16x CN¥-28.41 Million
2003 4.45% 0.88% 1.71x 2.95x CN¥-18.97 Million
2004 5.56% 1.26% 1.86x 2.36x CN¥-15.91 Million
2005 9.08% 2.19% 1.53x 2.72x CN¥-3.61 Million
2006 16.21% 1.28% 2.12x 5.98x CN¥27.78 Million
2007 25.80% 1.82% 2.37x 6.00x CN¥76.50 Million
2008 25.44% 1.82% 2.38x 5.87x CN¥96.99 Million
2009 23.43% 1.76% 2.09x 6.36x CN¥110.45 Million
2010 24.81% 2.00% 2.07x 5.99x CN¥155.88 Million
2011 24.32% 2.17% 1.97x 5.68x CN¥193.30 Million
2012 26.79% 2.64% 1.94x 5.23x CN¥298.20 Million
2013 23.19% 2.46% 1.92x 4.93x CN¥296.01 Million
2014 13.69% 2.72% 1.87x 2.69x CN¥176.04 Million
2015 17.01% 2.45% 2.86x 2.42x CN¥382.27 Million
2016 14.04% 2.88% 1.94x 2.52x CN¥341.52 Million
2017 11.26% 2.56% 1.85x 2.38x CN¥118.13 Million
2018 10.42% 2.81% 1.49x 2.49x CN¥48.90 Million
2019 9.90% 2.40% 1.57x 2.62x CN¥-12.71 Million
2020 10.05% 2.35% 1.51x 2.84x CN¥7.06 Million
2021 8.95% 1.96% 1.60x 2.87x CN¥-156.07 Million
2022 9.22% 2.02% 1.72x 2.64x CN¥-125.88 Million
2023 9.18% 2.12% 1.59x 2.73x CN¥-142.23 Million
2024 3.64% 0.86% 1.56x 2.69x CN¥-1.12 Billion

Industry Comparison

This section compares China National Accord Medicines Corp Ltd's net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

  • Industry: Medical Distribution
  • Average net assets among peers: $10,290,603,808
  • Average return on equity (ROE) among peers: 10.08%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
China National Accord Medicines Corp Ltd (000028) CN¥21.55 Billion 21.59% 1.35x $1.74 Billion
Shenzhen Glory Medical Co Ltd (002551) $2.82 Billion 2.12% 0.68x $442.93 Million
Shandong Realcan Pharmaceutical Co Ltd (002589) $5.64 Billion 0.36% 1.96x $700.19 Million
China National Accord Medicines Corp Ltd (200028) $357.13 Million 11.35% 0.25x $126.15 Million
Qingdao Baheal Medical INC. (301015) $2.60 Billion 26.55% 1.73x $1.90 Billion
China Meheco Co Ltd (600056) $1.54 Billion 15.23% 0.77x $2.27 Billion
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) $33.64 Billion 11.79% 1.22x $4.66 Billion
China National Medicines Corp Ltd (600511) $399.62 Million 6.55% 1.02x $3.16 Billion
Liaoning Cheng Da Co Ltd (600739) $20.00 Billion 4.74% 0.66x $2.66 Billion
Jointown Pharmaceutical Group Co Ltd (600998) $25.62 Billion 12.00% 2.16x $3.81 Billion

About China National Accord Medicines Corp Ltd

SHE:000028 China Medical Distribution
Market Cap
$1.74 Billion
CN¥11.91 Billion CNY
Market Cap Rank
#6775 Global
#1562 in China
Share Price
CN¥24.54
Change (1 day)
-1.05%
52-Week Range
CN¥24.41 - CN¥27.00
All Time High
CN¥2829.45
Categories
Companies in China Medical Distribution
About

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Weste… Read more